The ex-incentive operating loss narrowed from KRW 397.6 billion to KRW 127.7 billion, the largest sequential improvement in the five-quarter series, and it came from the operating line rather than the credit line. That is the strongest underlying data point LGES has produced since Q3 2025. In the same three months, KRW 1.330 trillion of EBITDA converted to KRW 25 billion of operating cash flow, working capital absorbed KRW 1.185 trillion, and total debt rose KRW 4.4 trillion. The operating trajectory and the balance-sheet trajectory moved in opposite directions this quarter.
Decomposition Table
All figures KRW billions, restated basis. LGES reclassified North American production incentives into revenue starting 2026 and restated 2025 comparatives; operating profit is unchanged across presentations. Q2 2026 USD equivalents use KRW 1,500.48/USD quarterly average.
| Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|
| Revenue | 6,056 | 6,065 | 6,474 | 6,555 | 7,560 ($5.04B) |
| Operating profit/(loss) | 492.2 | 601.3 | (122.0) | (207.8) | 113.3 ($75.5M) |
| NA production incentives | 490.8 | 365.5 | 332.8 | 189.8 | 241.0 |
| Operating profit/(loss) ex-incentive | 1.4 | 235.8 | (454.8) | (397.6) | (127.7) |
| Sequential change, ex-incentive | — | +234.4 | (690.6) | +57.2 | +269.9 |
| Utilization rate | ¹ | ¹ | ¹ | ¹ | ¹ |
| ASP direction | ² | ² | ² | ² | ² |
| EV/ESS revenue mix | ³ | ³ | ³ | ³ | ³ |
¹ LGES has not disclosed quarterly utilization for any quarter in this series. The most recent public figure is 47.6% for full-year 2025, which is not a comparable quarterly measure. ² Q2 materials do not disclose a numerical ASP or a quarterly ASP change. ³ Q1 management described ESS as mid-20% of revenue; Q2 placed H1 ESS share in the high-20% range. No quarter-specific split is available.
45X Isolation
The incentive line recovered off Q1's trough, KRW 189.8 billion to KRW 241.0 billion, and remains well below the Q2 2025 peak of KRW 490.8 billion. Across five quarters: 490.8, 365.5, 332.8, 189.8, 241.0. A step-down with a partial bounce. Q1's drop reflected lower US production volumes and a credit-recognition timing lag that management flagged on the Q1 call. The Q2 recovery lines up with the Tennessee and Ohio ESS lines entering production during the quarter.
Strip the KRW 241.0 billion and Q2 was a KRW 127.7 billion operating loss. In Q1, the underlying loss narrowed KRW 57 billion while the credit contribution fell KRW 143 billion. In Q2, the ex-incentive gap closed KRW 270 billion against a KRW 51 billion increase in the credit. Two consecutive quarters in which the operating result moved independently of the credit line, and in the second of them the operating movement was five times the credit movement.
The business still loses money without the credits, and the loss is now shrinking for operating reasons.
Utilization Trend
LGES has not disclosed a quarterly utilization rate for any quarter in this series. The 47.6% full-year 2025 figure from TrendForce via Yonhap is the latest available baseline. Without a quarterly rate against a stated capacity denominator, the second derivative cannot be assessed from public sources at all. What is available: revenue grew 15.3% QoQ, and management referenced higher European utilization and increased North American ESS production on the Q2 call. Directionally positive, but revenue growth against an undisclosed denominator is not a utilization read.
Q2 materials contained no update on LFP conversion progress, yield metrics, or per-kWh cost trajectory at any facility.
Guidance vs. Actuals
On the Q1 call, management guided two testable expectations for Q2: at least 10% sequential revenue growth, and company-wide operating breakeven excluding IRA incentives.
Revenue grew 15.3%. The ex-incentive result was a KRW 127.7 billion loss. Volume target exceeded, margin target missed. That pattern — top-line growth arriving ahead of cost stability on new lines — is normal for a production ramp, which is why the breakeven date rather than the breakeven gap is the variable worth tracking.
On the Q2 call, the target moved to Q4 2026, when management expects five ESS production sites to be stabilized and the ESS business to reach profitability excluding incentives. Whether Q3 moves it again tells you more than whether Q3 narrows the loss further.
EBITDA-to-Operating-Cash-Flow Gap
The operating improvement did not produce cash.
| KRW bn | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
| EBITDA | 1,375 | 1,519 | 913 | 887 | 1,330 |
| Operating cash flow | 250 | 1,267 | 1,753 | (316) | 25 |
| EBITDA − OCF | 1,125 | 252 | (840) | 1,203 | 1,305 |
| Working-capital contribution | 326 | (958) | 891 | (1,044) | (1,185) |
Source: LGES Q2 2026 earnings presentation. LGES notes this cash-flow presentation differs from the auditor's standard statement and includes deposits in cash equivalents.
Q1 was the break: operating cash flow at negative KRW 316 billion against KRW 887 billion of EBITDA. Q2 improved in absolute terms, back to positive KRW 25 billion, but the gap between the two widened from KRW 1.203 trillion to KRW 1.305 trillion, because EBITDA rose KRW 443 billion while OCF rose KRW 341 billion. The operating line moved further than the cash did.
Working capital is the mechanism, and Q2's KRW 1.185 trillion absorption is the largest figure in the series.
| Period-end, KRW bn | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
| Receivables | 4,595 | 4,849 | 4,311 | 5,157 | 5,975 |
| Inventory | 4,054 | 4,883 | 4,350 | 5,354 | 6,445 |
| Payables | 2,207 | 2,332 | 2,153 | 2,957 | 3,683 |
Through Q3 2025, receivables and inventory built moderately. Q4 released working capital as both pulled back. From Q1 2026 both reversed sharply. Across the two quarters from Q4 2025 to Q2 2026, receivables rose KRW 1.664 trillion and inventory rose KRW 2.095 trillion against a KRW 1.530 trillion increase in payables — the payable build offsetting roughly 41% of the gross asset-side build, leaving net absorption of approximately KRW 2.2 trillion.
The ESS ramp sits in the same window. Tennessee and Ohio entered production, ESS revenue grew approximately 30% QoQ per management commentary, and H1 ESS share reached the high-20% range. But the public materials do not attribute the working-capital build to ESS versus EV, to specific customers, or to specific facilities, and the cash-flow presentation is consolidated. Treat the link between the ESS ramp and the cash consumption as editorial inference: temporally coincident and mechanically plausible, not sourced to a segment-level disclosure.
The balance-sheet consequence is sourced. Total debt rose from KRW 24.682 trillion to KRW 29.123 trillion during the quarter. Current debt fell KRW 1.66 trillion while non-current debt rose KRW 6.1 trillion, which is a deliberate refinancing of short into long with net new leverage on top. The non-current increase includes roughly KRW 2.6 trillion in bonds, partly explained by a $1.6 billion foreign-currency issuance in April at 5.0–5.875% coupons with 2029–2036 maturities, and roughly KRW 2.4 trillion in lease liabilities, likely related in part to a sale-leaseback of L-H Battery facilities with Honda.
Approximately KRW 0.2 trillion of European Investment Bank borrowing is subject to a total-debt-to-EBITDA covenant below 4x. LGES had not met the condition at June 30 and reported the waiver process as underway. The exposure is immaterial against KRW 29 trillion of total debt, but the breach locates the balance sheet relative to a threshold an outside lender set in advance.
Sourcing Decision Frame
Q2 moved two variables that matter for supplier qualification in opposite directions. The operating trajectory produced the best ex-incentive result in five quarters, driven by volume and production ramp rather than credit timing. For anyone assessing whether LGES can produce cells at competitive cost over a 12–18 month horizon, this is the quarter to point to. The balance sheet complicates it: KRW 6.4 trillion of inventory, KRW 6.0 trillion of receivables, KRW 29.1 trillion of total debt, a covenant breach on EIB borrowing, and KRW 25 billion of operating cash flow against KRW 1.330 trillion of EBITDA. The ramp and its working-capital build are being funded by long-term debt issuance, a structure that holds while bond markets stay open and the ESS pipeline converts to shipped-and-collected revenue, and that becomes fragile if either condition changes. Roughly 40% of revenue still comes from the US market, which keeps the 45X trajectory and FEOC compliance status as first-order inputs to the risk profile; the absence of any disclosed LFP conversion metrics means the cost position of that US-produced ESS supply cannot be independently checked. Six months ago the question was whether LGES could reach operating breakeven — close to answered now. The question is whether the operating improvement converts to cash before the working-capital build constrains the ramp. Management's breakeven date is Q4. Watch whether working capital stabilizes when it arrives.
- EIB covenant waiver outcome: LGES reported the waiver process underway for its ~KRW 0.2 trillion EIB borrowing after missing the 4x debt-to-EBITDA test at June 30 — the H1 filing does not disclose the waiver deadline or whether a cure period applies.
- Tennessee and Ohio output: Both ESS facilities declared mass production in July, but neither the L-H Battery announcement nor the Yonhap report discloses current GWh, yield, customer-accepted shipments, or uncommitted capacity.
- Q4 breakeven target durability: Management shifted the ex-incentive breakeven target from Q2 to Q4 on the Q2 call, contingent on five ESS sites reaching stabilization — Q3 guidance language will indicate whether this date holds or slides again.
- Working-capital segment attribution: The consolidated cash-flow presentation does not allocate the KRW 1.185 trillion working-capital outflow between ESS and EV, so whether the ESS ramp is the primary cash consumer remains an untested hypothesis pending segment-level disclosure.

